Moreover, cancer patients also present with increased expression levels of platelet-derived substances in the circulation, including CD40 ligand (CD40L) [59], P-selectin [60], tissue factor (TF) [61] and platelet-derived microparticles (PMPs) [62, 63]. Here, CD40LG is linked to cancer.